Novavax
NVAX
134 hedge funds and large institutions have $157M invested in Novavax in 2017 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 45 increasing their positions, 34 reducing their positions, and 13 closing their positions.
46% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 13
32% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 34
22% more call options, than puts
Call options by funds: $1.36M | Put options by funds: $1.12M
20% more capital invested
Capital invested by funds: $132M → $157M (+$25.7M)
5% more funds holding
Funds holding: 128 → 134 (+6)
0.06% more ownership
Funds ownership: 1.96% → 2.02% (+0.06%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$8.33M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.94M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.9M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$1.62M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$1.44M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$3.87M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.18M |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$764K |
| 4 |
D.E. Shaw & Co
New York
|
-$442K |
| 5 |
Goldman Sachs
New York
|
-$391K |
NVAX Hedge Fund Activity: Q4 2017 in Review
134 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q4 2017, worth a combined $157M — up 20% from $132M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new NVAX positions and 13 closed out — a net gain of 6 holders — while 45 added to existing stakes and 34 trimmed.
The largest buyer was State Street, adding an estimated $8.33M. The largest seller was Millennium Management, cutting an estimated $3.87M.
- 134 institutional investors held Novavax (NVAX) as of Q4 2017, up from 128 in Q3 2017.
- Funds reported $157M of Novavax stock for Q4 2017, up 20% quarter-over-quarter.
- 19 funds opened new Novavax positions in Q4 2017 and 13 closed out, a net change of +6 holders.
- The largest Novavax buyer in Q4 2017 was State Street, an estimated $8.33M added.
- The largest Novavax seller in Q4 2017 was Millennium Management, an estimated $3.87M sold.
Based on aggregated 13F filings for Q4 2017.